Inpatient hospital care for psoriasis: a vanishing practice in the United States - 29/08/11
Abstract |
Background |
Inpatient hospital care was a traditional approach to treat severe psoriasis. Since 1980, only modest innovations in psoriasis therapy have been introduced, but regulation and financing of inpatient hospital care have changed greatly.
Objective |
We documented changes in the use of inpatient care in acute care hospitals for psoriasis in a cohort of individuals with severe psoriasis and nationally.
Methods |
Using interviews, we quantified hospitalizations for psoriasis and other reasons among the PUVA Follow-up Study cohort. We used National Hospital Discharge Survey data to determine national trends in hospitalization rates.
Results |
In 2 decades, national rates of hospitalization primarily for psoriasis decreased more than 80%. Among our cohort of persons with severe psoriasis, the age-adjusted rate of hospital days for psoriasis decreased more than 60% during this period.
Conclusion |
Currently, hospitalization in acute care hospitals is seldom used to care for persons with psoriasis.
Le texte complet de cet article est disponible en PDF.Plan
 | Conflicts of interest: None identified. The following centers and investigators participated in the PUVA Follow-up Study: Stanford University School of Medicine, Stanford, Calif, E. Bauer; University of California Medical School, San Francisco, Calif, J. H. Epstein, J. Koo; Baylor College of Medicine, Houston, Tex, J. Wolf; Washington Hospital Center, Washington, DC, T. P. Niagra; University of Michigan Medical School, Ann Arbor, Mich, T. F. Anderson; Columbia University College of Physicians and Surgeons, New York, NY, J. Prystowsky; Mayo Graduate School of Medicine, Rochester, Minn, M. McEvoy; University of Miami, Miami, Fla, J. R. Taylor; Mount Sinai Medical Center, Miami, Fla, N. Zaias; Temple University School of Medicine, Philadelphia, Pa, F. Urbach; Beth Israel Deaconess Medical Center, Boston, Mass, R. Stern; Dartmouth Medical School, Hanover, NH, R. D. Baughman; Yale University School of Medicine, New Haven, Conn, I. M. Braverman; Duke University Medical Center, Durham, NC, J. Murray; University of Pennsylvania Hospitals, Philadelphia, Pa, V. Werth; and Massachusetts General Hospital, Boston, Mass, J. Parrish, A. Sober. Supported in part by National Institutes of Health Contract N01-AR-4-2214 and N01-AR-0-2246. |
Vol 49 - N° 3
P. 445-450 - septembre 2003 Retour au numéro
Article précédent
- Medical management of neurofibromatosis 1: a cross-sectional study of 383 patients
- Jean-Christophe Drappier, Kiarash Khosrotehrani, Jacques Zeller, Jean Revuz, Pierre Wolkenstein
- Receive table of contents by email
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?